COMMUNIQUÉS West-GlobeNewswire

OSE Immunotherapeutics fait un point clinique sur Tedopi®, vaccin contre le cancer à base de néo-épitopes, dans le cancer du pancréas et dans le cancer du poumon non à petites cellules
02/06/2025
OSE Immunotherapeutics fait un point clinique sur Tedopi®, vaccin contre le cancer à base de néo-épitopes, dans le cancer du pancréas et dans le cancer du poumon non à petites cellules Deux présentations au congrès 2025 [...]
OSE Immunotherapeutics Provides Clinical Updates on Neo-Epitope Based Cancer Vaccine Tedopi® in Pancreatic Cancer and Non-Small Cell Lung Cancer
02/06/2025
OSE Immunotherapeutics Provides Clinical Updates on Neo-Epitope Based Cancer Vaccine Tedopi® in Pancreatic Cancer and Non-Small Cell Lung Cancer Two presentations at the American Society of Clinical Oncology (ASCO) 2025 [...]
DentPrime Signs New Sponsorship Agreement with Czech Republic's Renowned Ice Hockey Team Orli Znojmo
02/06/2025
ANTALYA, Turkey, June 02, 2025 (GLOBE NEWSWIRE) -- DentPrime , a leading brand in international health tourism renowned for delivering high-quality dental healthcare to thousands of patients across Europe, announced [...]
Elite Clinical Network Appoints Christopher Brennan as Chief Executive Officer
02/06/2025
SCOTTSDALE, Ariz., June 02, 2025 (GLOBE NEWSWIRE) -- Elite Clinical Network (ECN), a fully-integrated clinical research site network, has appointed Christopher (“Chris”) Brennan as its Chief Executive Officer. With 25 [...]
‘Stealthy’ Endocrine Effects of the COVID Vaccine Discussed in the Journal of American Physicians and Surgeons
02/06/2025
TUCSON, Ariz., June 02, 2025 (GLOBE NEWSWIRE) -- Endocrine effects that may result from vaccination are deceptively subtle at their onset. Hence, robust and sensitive pharmacovigilance is needed to discover them, writes [...]
The Worsening Pandemic of Gambling Highlighted in the Journal of American Physicians and Surgeons
02/06/2025
TUCSON, Ariz., June 02, 2025 (GLOBE NEWSWIRE) -- Gambling addiction is worse than substance abuse in many ways, including suicide rates, writes Andrew Schlafly , Esq. in the summer issue of the Journal of American [...]
Xilio Therapeutics Announces Pricing of $50.0 Million Public Offering
02/06/2025
WALTHAM, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living [...]
TerrAscend Announces Chief Financial Officer Transition Plan
02/06/2025
TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND, OTCQX: TSNDF) , a leading North American cannabis company, today announced that Keith Stauffer, Chief Financial [...]
Actuate Therapeutics Shares Highlights from KOL Event on Positive Topline Elraglusib Phase 2 Data in First-Line Treatment of Metastatic Pancreatic Cancer
02/06/2025
- Expert Insights on Clinical Relevance and Scientific Rationale - The replay of the event is available on the Investor Relations section of the Actuate website CHICAGO and FORT WORTH, Texas, June 02, 2025 (GLOBE [...]
New Independent Review Paper Strengthens Therapeutic Rationale for Artelo’s FABP Inhibitor Program in Anxiety and Depression
02/06/2025
SOLANA BEACH, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people [...]
PathAI and Northwestern Medicine Announce Strategic Collaboration to Deploy the AISight® Digital Pathology Platform and Co-Develop New AI Diagnostics
02/06/2025
Collaboration includes use of PathAI’s AISight®¹ digital pathology image management system at Northwestern Medicine and joint efforts in research, clinical innovation, and algorithm co-development to advance pathology- [...]
Liberation Labs is Now Liberation Bioindustries
02/06/2025
New name, new brand better reflects the company’s position as a global, commercial-scale biomanufacturer RICHMOND, Ind., June 02, 2025 (GLOBE NEWSWIRE) -- Liberation Labs has a new name and brand – Liberation [...]
Myriad Genetics Shares New Clinical Data Demonstrating Sensitivity of Precise MRD Across Multiple Cancer Types
02/06/2025
MONSTAR-SCREEN-3 study showed 100% detection of circulating tumor DNA (ctDNA) at baseline timepoint, and 60% of patients testing positive one month after surgery had tumor fractions only detectable via ultra-sensitive [...]
Full Dose-Escalation Data Show Continued High Response Rates and Favorable Safety Profile of ISB 2001, a First-in-Class BCMA × CD38 × CD3 Trispecific Antibody, for the Treatment of Relapsed/Refractory Multiple Myeloma
02/06/2025
TRIgnite-1 study shows an overall response rate (ORR) of 74% across nine dose levels, in heavily pretreated patients with a median of six prior lines of therapy ORR is remarkably high in patients with no prior CAR-T or [...]
Solera Health Unveils Enhanced AI Governance Framework for Responsible and Transparent Use of Artificial Intelligence in Digital Health
02/06/2025
Framework Sets an Industry Benchmark for Client Trust and Ethical AI Use to Ensure Patient Safety and Accountability PHOENIX, June 02, 2025 (GLOBE NEWSWIRE) -- Solera Health , the premier digital health delivery company [...]
Evosep unveils new instrumentation and partnership at ASMS 2025
02/06/2025
BALTIMORE, Md., June 02, 2025 (GLOBE NEWSWIRE) -- Evosep ® , a global leader in proteomics solutions, is proud to announce the launch of the Evosep Eno™, a robust, high-throughput separation tool preparing for next [...]
Cytrellis Strengthens Leadership Team in Support of Accelerated Commercial Growth of ellacor® Platform
02/06/2025
WOBURN, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Cytrellis Biosystems Inc., a medical technology company specializing in novel aesthetic solutions, today announced the appointment of Karyn Siemasko, Ph.D., as Vice [...]
Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY
02/06/2025
REYKJAVIK, Iceland, June 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its [...]
Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY
02/06/2025
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Jefferies Global Healthcare [...]

Pages